JNJ 26854165 dihydrochloride - Serdemetan dihydrochloride |
| カタログ番号GB40248 |
口内HDM2阻害剤（または拮抗剤）は、in vitroおよびex vivoで多発性骨髄腫（MM）細胞に対して強力な活性を示し、p53機能を回復させる可能性があり、他のHDM2依存経路にも影響を与える可能性がある有望な薬剤です。注：JNJ 26854165ジヒドロクロリドは、直接水溶性のJNJ 26854165の形式です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2109414-74-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Oral HDM2 inhibitor (or antagonist), which showed potent activity against multiple myeloma (MM) cells in vitro and ex vivo; potential agent to restore p53 function and to potentially impact other HDM2 dependent pathways.Note: JNJ 26854165 dihydrochloride is a directly water-soluble form of JNJ 26854165
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *